SR45

Serial Number 98619384
686

Registration Progress

Application Filed
Jun 26, 2024
Under Examination
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered

Basic Information

Serial Number
98619384
Filing Date
June 26, 2024
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
May 20, 2025
Application
Pending
Classes
005

Rights Holder

ANJAC

99
Address
15 Rue de la Banque
Paris 75002
FR

Ownership History

ANJAC

Original Applicant
99
Paris FR

ANJAC

Owner at Publication
99
Paris FR

Legal Representation

Attorney
Jeffrey Goehring

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jan 28, 2025 GNRT F NON-FINAL ACTION E-MAILED
Jan 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2025 DOCK D ASSIGNED TO EXAMINER
Jan 19, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2025 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 7, 2025 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jun 26, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for treating depression and anxiety; veterinary preparations for treating depression and anxiety; chemical preparations for medical purposes for treating depression-like symptoms, for low mood management, for relieving symptoms of anxiety, and for reducing anxiety and depression symptoms; chemical preparations for pharmaceutical purposes for treating depression-like symptoms, for low mood management, for relieving symptoms of anxiety, and for reducing anxiety and depression symptoms

Classification

International Classes
005